{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:22:01Z","timestamp":1792790521668,"version":"4.5.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0236506","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T21:48:51Z","timestamp":1596145731000},"page":"e0236506","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer"],"prefix":"10.1371","volume":"15","author":[{"given":"Jeong-Ju","family":"Yoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Seok","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zisun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8694-777X","authenticated-orcid":true,"given":"Sang Gyune","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7113-3623","authenticated-orcid":true,"given":"Young Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,7,30]]},"reference":[{"issue":"8","key":"pone.0236506.ref001","first-page":"688","article-title":"The natural history of hormone receptor-positive breast cancer","volume":"26","author":"E Lim","year":"2012","journal-title":"Oncology"},{"issue":"9114","key":"pone.0236506.ref002","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group","volume":"351","year":"1998","journal-title":"Lancet"},{"issue":"8","key":"pone.0236506.ref003","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJM198902233200802","article-title":"A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors","volume":"320","author":"B Fisher","year":"1989","journal-title":"The New England journal of medicine"},{"issue":"17","key":"pone.0236506.ref004","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jnci\/djr242","article-title":"Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis","volume":"103","author":"E Amir","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"pone.0236506.ref005","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/liv.14434","article-title":"Prevalence, incidence and risk factors of tamoxifen-related non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"40","author":"B Lee","journal-title":"Liver Int. 2020"},{"key":"pone.0236506.ref006","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejca.2017.05.002","article-title":"Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study","volume":"82","author":"N Hong","year":"2017","journal-title":"Eur J Cancer"},{"issue":"1","key":"pone.0236506.ref007","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2214\/ajr.180.1.1800129","article-title":"Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy","volume":"180","author":"M Nishino","year":"2003","journal-title":"AJR American journal of roentgenology"},{"issue":"9869","key":"pone.0236506.ref008","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"C Davies","year":"2013","journal-title":"Lancet"},{"issue":"7497","key":"pone.0236506.ref009","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.38391.663287.E0","article-title":"Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial","volume":"330","author":"S Bruno","year":"2005","journal-title":"Bmj"},{"issue":"1","key":"pone.0236506.ref010","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"N Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"pone.0236506.ref011","doi-asserted-by":"crossref","first-page":"310","DOI":"10.6004\/jnccn.2018.0012","article-title":"Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"16","author":"WJ Gradishar","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"pone.0236506.ref012","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"S Saadeh","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"pone.0236506.ref013","first-page":"419","article-title":"Imaging diagnosis and quantification of hepatic steatosis: is it an accepted alternative to needle biopsy?","volume":"14","author":"M Lupsor","year":"2005","journal-title":"Romanian journal of gastroenterology"},{"issue":"1","key":"pone.0236506.ref014","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1148\/radiol.2301021176","article-title":"Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings","volume":"230","author":"P Limanond","year":"2004","journal-title":"Radiology"},{"issue":"3","key":"pone.0236506.ref015","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MEG.0000000000000277","article-title":"MDCT classification of steatotic liver: a multicentric analysis","volume":"27","author":"L Saba","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"pone.0236506.ref016","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4103\/0971-3026.143897","article-title":"Preoperative CT evaluation of potential donors in living donor liver transplantation","volume":"24","author":"S Vohra","year":"2014","journal-title":"The Indian journal of radiology & imaging"},{"key":"pone.0236506.ref017","volume-title":"Applied survival analysis: regression modeling of time-to-event data","author":"W. David","year":"2011"},{"issue":"2","key":"pone.0236506.ref018","doi-asserted-by":"crossref","first-page":"e88238","DOI":"10.1371\/journal.pone.0088238","article-title":"Extended adjuvant tamoxifen for early breast cancer: a meta-analysis","volume":"9","author":"M Al-Mubarak","year":"2014","journal-title":"PloS one"},{"issue":"6","key":"pone.0236506.ref019","first-page":"411","article-title":"Association between tamoxifen treatment and the development of different stages of nonalcoholic fatty liver disease among breast cancer patients. Journal of the Formosan Medical Association =","volume":"115","author":"HJ Pan","year":"2016","journal-title":"Taiwan yi zhi"},{"key":"pone.0236506.ref020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.breast.2016.04.017","article-title":"Clinical significance of fatty liver disease induced by tamoxifen and toremifene in breast cancer patients","volume":"28","author":"YJ Yang","year":"2016","journal-title":"Breast"},{"issue":"1","key":"pone.0236506.ref021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14740338.6.1.1","article-title":"Tamoxifen-induced non-alcoholic steatohepatitis: where are we now and where are we going?","volume":"6","author":"KA Osman","year":"2007","journal-title":"Expert opinion on drug safety"},{"key":"pone.0236506.ref022","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of Estrogens in the Regulation of Liver Lipid Metabolism","volume":"1043","author":"BT Palmisano","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"pone.0236506.ref023","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/cam4.37","article-title":"Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer","volume":"1","author":"R Haque","year":"2012","journal-title":"Cancer medicine"},{"issue":"Suppl 8","key":"pone.0236506.ref024","doi-asserted-by":"crossref","first-page":"viii26","DOI":"10.1093\/annonc\/mdm263","article-title":"Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer","volume":"18","author":"EA Perez","year":"2007","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"4","key":"pone.0236506.ref025","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.1016\/j.clbc.2017.11.010","article-title":"Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients","volume":"18","author":"HT Chang","year":"2018","journal-title":"Clinical breast cancer"},{"issue":"7","key":"pone.0236506.ref026","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.acra.2012.02.022","article-title":"Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis","volume":"19","author":"I Zeb","year":"2012","journal-title":"Acad Radiol"},{"issue":"1","key":"pone.0236506.ref027","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1148\/radiol.2391050361","article-title":"Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment","volume":"239","author":"SH Park","year":"2006","journal-title":"Radiology"},{"issue":"8","key":"pone.0236506.ref028","doi-asserted-by":"crossref","first-page":"530","DOI":"10.4254\/wjh.v10.i8.530","article-title":"Current status of imaging in nonalcoholic fatty liver disease","volume":"10","author":"Q Li","year":"2018","journal-title":"World J Hepatol"},{"issue":"10","key":"pone.0236506.ref029","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/RLI.0b013e318261fad0","article-title":"Quantification of hepatic steatosis with dual-energy computed tomography: comparison with tissue reference standards and quantitative magnetic resonance imaging in the ob\/ob mouse","volume":"47","author":"NS Artz","year":"2012","journal-title":"Invest Radiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0236506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T06:35:48Z","timestamp":1667630148000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0236506"}},"subtitle":[],"editor":[{"given":"Hakan","family":"Buyukhatipoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0236506","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,30]]}}}